Tangential Flow Filtration Market Product (Cassettes, Cartridges) Business Growth Opportunities
Tangential Flow Filtration Market report categorizes the Global Market by Product (Cassettes, Cartridges), Membrane Material (Polyethersulfone, Regenerated Cellulose), Technology & Geography
(EMAILWIRE.COM, August 29, 2018 ) The global tangential flow filtration market is poised to reach USD 1,005.0 Million by 2021 from USD 554.7 Million in 2016, at a CAGR of 12.6% from 2016 to 2021. In this report, the global market is segmented on the basis of product, membrane material, technology, pore size/MWCO, application, and region.
Know More: https://www.marketsandmarkets.com/Market-Reports/tangential-flow-filtration-market-72081607.html
Based on product, the market is categorized into single-use systems, reusable systems, membrane filters, and filtration accessories. In this market, single-use systems form the fastest-growing segment, due to the increasing adoption of single-use devices and technologies in the bioprocessing and other applications.
On the basis of membrane material, the tangential flow filtration market is classified into polyethersulfone, regenerated cellulose, and other materials. The other materials segment includes polyvinylidene fluoride and ceramic materials.
The technology segments covered in this report include ultrafiltration, microfiltration, and reverse osmosis. The ultrafiltration segment is estimated to account for the highest growth of the market in 2016, due to usage of this technology in the production of biologicals. On the basis of pore size/MWCO, the market is classified into ultrafilters, microfilters, and reverse osmosis filters. The ultrafilters segment is estimated to account for the highest growth of the market in 2016.
The growth of the market is propelled by the growth in the biopharmaceutical industry, growth in the adoption of single-use technologies, and advantages of tangential flow filtration over normal flow filtration. Furthermore, market growth is supported by R&D spending and increasing investment opportunities in emerging and immature markets.
Key players operating in the market are Danaher Corporation (U.S.), Merck Millipore (U.S.), Sartorius Stedim Biotech S.A. (France), Parker Hannifin Corporation (U.S.), GE Healthcare (U.S.), Alfa Laval AB (Sweden), Spectrum Laboratories (U.S.), and Novasep (U.S.).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=72081607
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com